AzurBio Pharma is the partner of choice for biopharma companies looking to launch their innovation in rare or serious diseases in the European market.
With a dual presence in the US and Europe, we are supporting North American companies to access the EU market by maximizing flexibility and minimizing operational burden.
Company Details
- Employees
- 11
- Founded
- 2022
- Address
- 32, Avenue Kléber, Paris,île-De-France 75116,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://azurbio-pharma.com/
- HQ
- Paris, Île-de-France
Azurbio Pharma Questions
Azurbio Pharma's website is https://azurbio-pharma.com/
Azurbio Pharma's LinkedIn profile is https://www.linkedin.com/company/azurbio-pharma
Azurbio Pharma has
11 employees.
View email and phone details for 11
employees at Azurbio Pharma.
Azurbio Pharma's industry is
Biotechnology Research
Azurbio Pharma's top competitors are
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Regor Therapeutics Group,
Eagle Pharmaceuticals, Inc.,
Septerna,
Aktis Oncology,
Kailera Therapeutics,
Curon Biopharmaceutical,
Triveni Bio,
Trevena, Inc.,
Grifols.
Azurbio Pharma's categories are Biotechnology Research
Azurbio Pharma's founding year is 2022
